News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Isogenica Limited, Cresset Group and Biolauncher Secure Funding from UK's Technology Strategy Board for a £1 Million Project to Develop New Small Molecule Drug Platform


6/6/2012 11:57:46 AM

CAMBRIDGE, England--(BUSINESS WIRE)--Today Wednesday 6th June 2012, Isogenica and Biolauncher, Cambridge UK together with Cresset Group, Welwyn Garden City UK announce funding from the Technology Strategy Board, the UK’s innovation agency, for a £1M project to develop a highly-scalable approach to small molecule drug discovery.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES